What are we looking for?

Digital Biomarkers in the seven research areas

  • Cognition and attention
  • Fatigue
  • Sleep
  • Depression and mood
  • Pain
  • Mobility
  • Digital imaging of skin

Who is eligible for this challenge?

Companies, start-ups, and academic research groups with the state-of-art technology in the above mentioned research areas are all welcome to apply!

What could you expect?

A collaboration opportunity with a global Pharma research team. Budgets is available in advanced stages.

The procedure:

  • Step 1: The primary screening will be conducted jointly by ETBA and Novartis Taiwan.
  • Step 2: The initial assessment will be executed by the Novartis Institutes for BioMedical Research (NIBR), including workshops and device evaluation.
  • Step 3: For promising solutions, formal collaboration will be established and the solution will be deployed in Novartis clinical studies.


November 30, 2020, at 11:00 CET / 18:00 TPE time

To learn more: